<?xml version="1.0" encoding="UTF-8" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
    <channel>
        <title>Value Research Online</title>
        <atom:link href="/stories/stock/249940/metropolis-healthcare-ltd/rss/" rel="self" type="application/rss+xml" />
        <link>https://www.valueresearchonline.com/</link>
        <description>RSS Feeds | Value Research</description>
        <language>en</language>
        <copyright>Copyright 2026 Value Research India Private Limited.</copyright>
        <image>
            <title>Value Research</title>
            <url>https://www.valueresearchonline.com/assets/images/valueresearchonline-desktop.png</url>
            <link>https://www.valueresearchonline.com/</link>
        </image>

        <item>
			<title>Sticking with experts during uncertainty</title>
			<link>https://www.valueresearchonline.com/stories/48495/sticking-with-experts-during-uncertainty/</link>
			<pubDate>Wed, 02 Sep 2020 09:45:54 +0530</pubDate>
			<category>Stockwire</category>
			<description>&lt;img src=&quot;https://www.valueresearchonline.com/content-assets/images/48495_mutual-fund-and-fiis-increasing-stake__w320__h240__.jpg&quot; alt=&quot;Sticking with experts during uncertainty&quot; border=&quot;0&quot; width=&quot;320&quot; height=&quot;240&quot; style=&quot;float: left; margin-right: 5px;&quot;&gt;Two mid-cap stocks where both foreign &amp; domestic investors raised their stakes by more than 1.5 per cent</description>
			<guid isPermaLink="true">https://www.valueresearchonline.com/stories/48495/sticking-with-experts-during-uncertainty/</guid>
		</item>
		<item>
			<title>Metropolis Healthcare IPO: Information analysis</title>
			<link>https://www.valueresearchonline.com/stories/46759/metropolis-healthcare-ipo-information-analysis/</link>
			<pubDate>Tue, 02 Apr 2019 18:06:19 +0530</pubDate>
			<category>IPO Analysis</category>
			<description>&lt;img src=&quot;https://www.valueresearchonline.com/content-assets/images/46759_metropolis__w320__h240__.jpg&quot; alt=&quot;Metropolis Healthcare IPO: Information analysis&quot; border=&quot;0&quot; width=&quot;320&quot; height=&quot;240&quot; style=&quot;float: left; margin-right: 5px;&quot;&gt;From a standalone laboratory to 115 clinical laboratories at present, Metropolis has come a long way. But will its high valuations &amp; highly concentrated revenues be a bane for investors?</description>
			<guid isPermaLink="true">https://www.valueresearchonline.com/stories/46759/metropolis-healthcare-ipo-information-analysis/</guid>
		</item>
    </channel>
</rss>
